We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNAM
751
DELISTED
Avidity Biosciences
RNAM
| $1.26M | ﹤0.01% |
27,336
+10,180
| +59% | +$442K |
|
752
Insight Enterprises
NSIT
$3.55B
| $1.25M | ﹤0.01% |
5,823
+1,502
| +35% | +$309K |
|
753
Krystal Biotech
KRYS
$9.88B
| $1.25M | ﹤0.01% |
6,881
+1,727
| +34% | +$333K |
|
754
Essential Properties Realty Trust
EPRT
$6.99B
| $1.25M | ﹤0.01% |
36,601
+12,193
| +50% | +$377K |
|
755
Option Care Health
OPCH
$3.4B
| $1.25M | ﹤0.01% |
39,877
+9,217
| +30% | +$283K |
|
|
GTLS
756
DELISTED
Chart Industries
GTLS
| $1.24M | ﹤0.01% |
9,956
+2,211
| +29% | +$290K |
|
757
Alkermes
ALKS
$8.82B
| $1.23M | ﹤0.01% |
43,937
+7,886
| +22% | +$210K |
|
|
COOP
758
DELISTED
Mr. Cooper
COOP
| $1.23M | ﹤0.01% |
13,330
+3,392
| +34% | +$301K |
|
759
Installed Building Products
IBP
$6.13B
| $1.23M | ﹤0.01% |
4,987
+1,341
| +37% | +$303K |
|
760
Petco
WOOF
$745M
| $1.23M | ﹤0.01% |
269,756
-14,908
| -5% | -$50.6K |
|
761
Sarepta Therapeutics
SRPT
$1.66B
| $1.22M | ﹤0.01% |
9,793
-493
| -5% | -$68.2K |
|
762
Central Garden & Pet Co
CENT
$2.74B
| $1.22M | ﹤0.01% |
33,412
-2,796
| -8% | -$108K |
|
763
ADMA Biologics
ADMA
$1.92B
| $1.22M | ﹤0.01% |
60,911
+18,048
| +42% | +$281K |
|
764
Glacier Bancorp
GBCI
$6.55B
| $1.21M | ﹤0.01% |
26,471
-161,575
| -86% | -$6.98M |
|
765
Brink's
BCO
$5.02B
| $1.2M | ﹤0.01% |
10,417
+2,330
| +29% | +$247K |
|
766
Moog Inc Class A
MOG.A
$13B
| $1.2M | ﹤0.01% |
5,934
+1,495
| +34% | +$281K |
|
767
Varonis Systems
VRNS
$5.25B
| $1.2M | ﹤0.01% |
21,206
+6,264
| +42% | +$329K |
|
768
Hasbro
HAS
$12.6B
| $1.2M | ﹤0.01% |
16,530
-1,338
| -7% | -$86.9K |
|
769
W.P. Carey
WPC
$17.1B
| $1.19M | ﹤0.01% |
19,080
+8,760
| +85% | +$519K |
|
770
Ryman Hospitality Properties
RHP
$8.4B
| $1.19M | ﹤0.01% |
11,084
+3,261
| +42% | +$333K |
|
771
Home BancShares
HOMB
$6.21B
| $1.18M | ﹤0.01% |
43,703
+9,605
| +28% | +$256K |
|
772
Merit Medical Systems
MMSI
$4.43B
| $1.18M | ﹤0.01% |
11,959
+3,180
| +36% | +$291K |
|
773
Knife River
KNF
$4.43B
| $1.18M | ﹤0.01% |
13,204
+2,949
| +29% | +$230K |
|
774
Federal Signal
FSS
$7.25B
| $1.17M | ﹤0.01% |
12,566
+3,313
| +36% | +$303K |
|
775
Dycom Industries
DY
$12.9B
| $1.17M | ﹤0.01% |
5,940
+1,517
| +34% | +$274K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.